Haemato AG (HAEK) — Capital Reinvestment Ratio
Latest as of December 2022:
0.06x
Haemato AG (HAEK) has a Capital Reinvestment Ratio of 0.06x as of December 2022, meaning it reinvests 0% of its operating cash flow (€19.73 Million) in capital expenditures (€1.09 Million). See HAEK FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
€19.73 Million
EUR
Capital Expenditures
€1.09 Million
EUR
Data as of
Dec 2022
Most recent filing
Haemato AG Capital Reinvestment Ratio (2021–2022)
This chart tracks Haemato AG's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Haemato AG (2021–2022)
Year-by-year Capital Reinvestment Ratio for Haemato AG from 2021 to 2022. For live market cap and broader valuation context, see HAEK market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.06x | €19.73 Million | €1.09 Million | ▲ +137.4% |
| 2021 | 0.02x | €14.05 Million | €326.75K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow